Leiomyoma: Genetics, assisted reproduction, pregnancy and therapeutic advances

Gary Levy, Micah J. Hill, Stephanie Beall, Shvetha M. Zarek, James Segars, William H. Catherino

Research output: Contribution to journalArticle

Abstract

Purpose: Uterine leiomyomas are common, benign, reproductive tract tumors affecting a majority of reproductive aged women. They are associated with gynecologic morbidity and detrimentally affect reproductive potential. The etiology of leiomyomas is poorly understood and their diagnosis prior to treatment with Assisted Reproductive Technologies (ART) represents a management dilemma. The purpose of this paper is to review known genetic and molecular contributions to the etiologies of leiomyomas, describe their impact on ART outcomes and reproductive potential, and review alternative therapies and future directions in management. Methods: A critical review of the literature pertaining to genetic component of uterine leiomyomas, their impact on ART and pregnancy and leiomyoma therapeutics was performed. Results: Uterine leiomyomas are characterized by complex molecular mechanisms. Their location and size determines their potential detriment to ART and reproductive function and novel therapeutic modalities are being developed. Conclusion: The high prevalence of uterine leiomyomas and their potential detrimental influence on ART and reproductive function warrants continued well-designed studies to ascertain their etiology, optimal treatment and novel less morbid therapies.

Original languageEnglish (US)
Pages (from-to)703-712
Number of pages10
JournalJournal of Assisted Reproduction and Genetics
Volume29
Issue number8
DOIs
StatePublished - Aug 2012
Externally publishedYes

Fingerprint

Leiomyoma
Reproduction
Assisted Reproductive Techniques
Pregnancy
Therapeutics
Complementary Therapies
Molecular Biology
Morbidity
Neoplasms

Keywords

  • Assisted reproductive technologies
  • Leiomyoma
  • Leiomyoma genetics

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Reproductive Medicine
  • Developmental Biology
  • Genetics
  • Genetics(clinical)

Cite this

Leiomyoma : Genetics, assisted reproduction, pregnancy and therapeutic advances. / Levy, Gary; Hill, Micah J.; Beall, Stephanie; Zarek, Shvetha M.; Segars, James; Catherino, William H.

In: Journal of Assisted Reproduction and Genetics, Vol. 29, No. 8, 08.2012, p. 703-712.

Research output: Contribution to journalArticle

Levy, Gary ; Hill, Micah J. ; Beall, Stephanie ; Zarek, Shvetha M. ; Segars, James ; Catherino, William H. / Leiomyoma : Genetics, assisted reproduction, pregnancy and therapeutic advances. In: Journal of Assisted Reproduction and Genetics. 2012 ; Vol. 29, No. 8. pp. 703-712.
@article{9915e606e06c46c6a1ecef86bfaaea62,
title = "Leiomyoma: Genetics, assisted reproduction, pregnancy and therapeutic advances",
abstract = "Purpose: Uterine leiomyomas are common, benign, reproductive tract tumors affecting a majority of reproductive aged women. They are associated with gynecologic morbidity and detrimentally affect reproductive potential. The etiology of leiomyomas is poorly understood and their diagnosis prior to treatment with Assisted Reproductive Technologies (ART) represents a management dilemma. The purpose of this paper is to review known genetic and molecular contributions to the etiologies of leiomyomas, describe their impact on ART outcomes and reproductive potential, and review alternative therapies and future directions in management. Methods: A critical review of the literature pertaining to genetic component of uterine leiomyomas, their impact on ART and pregnancy and leiomyoma therapeutics was performed. Results: Uterine leiomyomas are characterized by complex molecular mechanisms. Their location and size determines their potential detriment to ART and reproductive function and novel therapeutic modalities are being developed. Conclusion: The high prevalence of uterine leiomyomas and their potential detrimental influence on ART and reproductive function warrants continued well-designed studies to ascertain their etiology, optimal treatment and novel less morbid therapies.",
keywords = "Assisted reproductive technologies, Leiomyoma, Leiomyoma genetics",
author = "Gary Levy and Hill, {Micah J.} and Stephanie Beall and Zarek, {Shvetha M.} and James Segars and Catherino, {William H.}",
year = "2012",
month = "8",
doi = "10.1007/s10815-012-9784-0",
language = "English (US)",
volume = "29",
pages = "703--712",
journal = "Journal of Assisted Reproduction and Genetics",
issn = "1058-0468",
publisher = "Springer New York",
number = "8",

}

TY - JOUR

T1 - Leiomyoma

T2 - Genetics, assisted reproduction, pregnancy and therapeutic advances

AU - Levy, Gary

AU - Hill, Micah J.

AU - Beall, Stephanie

AU - Zarek, Shvetha M.

AU - Segars, James

AU - Catherino, William H.

PY - 2012/8

Y1 - 2012/8

N2 - Purpose: Uterine leiomyomas are common, benign, reproductive tract tumors affecting a majority of reproductive aged women. They are associated with gynecologic morbidity and detrimentally affect reproductive potential. The etiology of leiomyomas is poorly understood and their diagnosis prior to treatment with Assisted Reproductive Technologies (ART) represents a management dilemma. The purpose of this paper is to review known genetic and molecular contributions to the etiologies of leiomyomas, describe their impact on ART outcomes and reproductive potential, and review alternative therapies and future directions in management. Methods: A critical review of the literature pertaining to genetic component of uterine leiomyomas, their impact on ART and pregnancy and leiomyoma therapeutics was performed. Results: Uterine leiomyomas are characterized by complex molecular mechanisms. Their location and size determines their potential detriment to ART and reproductive function and novel therapeutic modalities are being developed. Conclusion: The high prevalence of uterine leiomyomas and their potential detrimental influence on ART and reproductive function warrants continued well-designed studies to ascertain their etiology, optimal treatment and novel less morbid therapies.

AB - Purpose: Uterine leiomyomas are common, benign, reproductive tract tumors affecting a majority of reproductive aged women. They are associated with gynecologic morbidity and detrimentally affect reproductive potential. The etiology of leiomyomas is poorly understood and their diagnosis prior to treatment with Assisted Reproductive Technologies (ART) represents a management dilemma. The purpose of this paper is to review known genetic and molecular contributions to the etiologies of leiomyomas, describe their impact on ART outcomes and reproductive potential, and review alternative therapies and future directions in management. Methods: A critical review of the literature pertaining to genetic component of uterine leiomyomas, their impact on ART and pregnancy and leiomyoma therapeutics was performed. Results: Uterine leiomyomas are characterized by complex molecular mechanisms. Their location and size determines their potential detriment to ART and reproductive function and novel therapeutic modalities are being developed. Conclusion: The high prevalence of uterine leiomyomas and their potential detrimental influence on ART and reproductive function warrants continued well-designed studies to ascertain their etiology, optimal treatment and novel less morbid therapies.

KW - Assisted reproductive technologies

KW - Leiomyoma

KW - Leiomyoma genetics

UR - http://www.scopus.com/inward/record.url?scp=84867067016&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867067016&partnerID=8YFLogxK

U2 - 10.1007/s10815-012-9784-0

DO - 10.1007/s10815-012-9784-0

M3 - Article

C2 - 22584729

AN - SCOPUS:84867067016

VL - 29

SP - 703

EP - 712

JO - Journal of Assisted Reproduction and Genetics

JF - Journal of Assisted Reproduction and Genetics

SN - 1058-0468

IS - 8

ER -